1. Introduction {#s0005}
===============

The off-label prescription of medicine for pediatric patients is a common practice worldwide ([@b0060]). Off-label medicines are medication that have been prescribed outside of their product license in terms of their recomended age, recommended dosage, method of administering or advised use ([@b0060]). A review from 1985 to 2004 by [@b0015] revealed that up to 80% of prescriptions to children were prescribed in an off-label manner. Such a finding raises concerns about the safety and effectiveness of medication when they are prescribed to pediatric patients in this manner ([@b0040], [@b0050]). It therefore emphasizes the importance of the role of healthcare providers in making sure that pediatric medicines are employed in the most appropriate manner ([@b0080]).

The prescription of pediatric off-label medication has raised significant concerns with respect to reported increased rates and seriousness of adverse drug reactions (ADRs): There are also issues surrounding the possibility that the prescribed treatments will fail, as well as the problem of ensuring the safety and efficacy of any treatments administered over long term ([@b0080]). Nonetheless, the prescription of off-label medication is commonplace since more beneficial treatments for children are often not available, while trials for many medicines intended for children have in fact not been carried out ([@b0085]).

Prior studies have attempted to gain some understanding of the opinions and experience of healthcare professionals with regards to the phenomena of off-label prescriptions for children ([@b0025], [@b0035], [@b0040], [@b0050], [@b0075]). It has been found that healthcare professionals have a moderate level of awareness of this issue, which they obtained through their profession experience and development, as well as through their undergraduate and post-graduate education and training.

The research presented in this work was designed to build upon previous literature and to examine the knowledge and attitudes towards the prescription of off-label medication in Jordan. The importance of this arises from the fact that most previous work dealing with the prescription of off-label medicines has been undertaken in the USA, the United Kingdom and other European countries ([@b0035], [@b0040], [@b0045], [@b0075]). In fact, this paper represents the first study of these issues, from a pharmaceutical perspective, with the entire Middle East.

The objective of this study is to examine the perceptions and attitudes of Jordanian hospital pharmacists towards the dispensing of off-label medicines to pediatric patients.

2. Methodology {#s0010}
==============

2.1. Questionnaire development {#s0015}
------------------------------

Following a review of the literature, a questionnaire was developed which, while focusing mainly on the use of off-label pediatric medicines, also looked into the role of hospital based pharmacists in terms of giving information to parents about the use of off-label medicines in pediatric patients. The questionnaire was mainly based on those previously used to explore the views, attitudes, knowledge, and perceptions of different healthcare professionals towards the use of unlicensed and off-label medicines in pediatric patients ([@b0025], [@b0035], [@b0075], [@b0040], [@b0050]). Most of the questions had pre-formulated answers, except for those where a reason for the participant′s answer was required. The resulting questionnaire consisted of a total of 27 questions.

The questionnaire was divided into four sections addressing different topics of interest. The first section (questions 1--9) focused on the area of medicine use in pediatric patients and on the use of off-label medicines for pediatrics. The second part (questions 10--13) was concerned with the involvement of parents in deciding what medicine will be prescribed to their child. The third section (questions 14--16) dealt with issues surrounding the dosages recommended when dispensing off-label medicines to pediatric patients. The fourth and final section (questions 17--27) involved collecting the participants' details and relevant demographic information in order to assess any variability in the responses as a function of these factors. As part of the questionnaire, information about the off-label use of medicines in pediatric patients, including definitions and relevant examples, was provided to assist those participants who may not have been familiar with the employed terminology.

The questionnaire was first issued to a small sample of pharmacist (n = 20) working at the School of Pharmacy of the Jordan University of Science and Technology. These participants informed the authors that the questionnaire was clear and easily understood. Note, while these questionnaires were not included in the final analysis, they nonetheless showed similar results as those making up the rest of the study.

2.2. Data collection {#s0020}
--------------------

The final questionnaire was distributed to a selection of pharmacists working in a list of randomly chosen hospitals. Hospitals were randomly selected from a list including all hospitals in Jordan. Before data collection, a letter was sent to pharmacy departments of all hospitals who were selected to take part in the study. The letters were sent to the head of each pharmacy department to ask them if they were willing to have their pharmacists take part in this study and if this was the case, they were also asked to indicate the number of questionnaires that would be required in each unit. Twelve hospitals agreed to take part in the study, seven public hospitals, four private hospitals, and one university hospital. In August and September 2014, questionnaires were provided to those departments who had agreed to take part in the study, asking that they complete it within four weeks. Those who had not completed the questionnaire within four weeks were allowed another two-week period before the questionnaire was collected again.

2.3. Ethical approval {#s0025}
---------------------

The study received ethical approval from the Institutional review board at King Abdulla University Hospital in May 2014 (REF: 73-2014). The study was undertaken following the ethical methods and standards outlined in the guidelines provided by the World Medical Association Declaration of Helsinki ([@b0005]).

2.4. Data analysis {#s0030}
------------------

After collecting the completed questionnaires, the responses were transcribed and entered into SPSS for Windows, version 21, for statistical analyses. The main descriptive analysis was carried out using the derived mean and standard deviations (SD) for the continuous parameters, and percentages for the qualitative variables.

3. Results {#s0035}
==========

3.1. Demographics {#s0040}
-----------------

The questionnaires were distributed to a total of 250 randomly-selected pharmacies based in hospitals distributed throughout Jordan. A response rate of 60% (n = 150) was obtained after two visits. The majority of participants were female (62%, n = 93). Regarding their experience years, 70% (n = 105), had been working as hospital pharmacists for more than ten years and the majority of participants (80%, n = 120) reported more than 20 h per week of direct patient contact. The majority of participants (60%, n = 90) reported that pediatric prescriptions formed more than 20% of their dispensing workload. Only 20% (n = 30) of participants reported that they had postgraduate education and only 16% (n = 24) reported that they gained their pharmacy degree from universities abroad. The demographic characteristics of the study participants are summarized in [Table 1](#t0005){ref-type="table"}.Table 1Demographic data of respondents.VariableResultsGender*N* = 150Male\
40%Female\
60%Experience years (years)*N* = 150\<5\
12%5--9\
18%10--14\
32%15--19\
15%\>19\
23%Patient contact per week (hours)*N* = 150\<10\
9%10--19\
11%20--29\
24%30--39\
40%\>39\
16%Pediatric dispensing workload, %*N* = 150\<10\
13%10--19\
15%20 +\
 60%Don\'t know\
12%Graduation country*N* = 150Jordan\
84%Abroad\
16%Highest degree obtained*N* = 150BSc\
80%MSc\
20%PhD\
0%Work place*N* = 150Private hospita\
l 20%Public hospital\
62%University hospital\
18%[^1]

3.2. Off-label dispensing {#s0045}
-------------------------

Less than half the participants taking part in the study (44%, n = 66) stated that they were aware of off-label Dispensing. Of those who were familiar with it, 65.2% (n = 43) said that they had learned of this through their dispensing experience as opposed to their undergraduate (13.6%, n = 9) or postgraduate education (21.2%, n = 16).

Within their own practice, 36% (n = 54) of participants admitted that they had knowingly dispensed off-label prescriptions meant for pediatric patients. Meanwhile, 22% (n = 33) denied undertaking any such actions, while 42% (n = 63) were unsure if they had or hadn′t, as indicated in [Fig. 1](#f0005){ref-type="fig"}.Fig. 1Knowingly dispensing off-label prescriptions to children.

Of those participants who admitted that they had dispensed off-label medicines meant for children, 30% (n = 45) reported failures in the prescribed treatment. Furthermore, 14% (n = 21) reported adverse drug reactions arising when dispensing such medicines for children. The most common reasons the dispensed medicines being described as off-label were; the child′s age was younger than recommended (88%, n = 132), a higher than recommended dose was prescribed (70%, n = 105), and different indication (42%, n = 63) (see [Fig. 2](#f0010){ref-type="fig"}).Fig. 2The most common reasons for off-label dispensed prescriptions.

Among the participants, 18% had major concerns with regards to the effectiveness of the off-label medicines prescribed to pediatric patients (n = 37), while 64% had minor concerns (n = 96), with only 12% (n = 18) of participants having no concerns.

The participants also often had concerns about the safety of off-label prescriptions for children. A minority (32%, n = 48) of participants had major concerns, 66% (n = 99) had minor concerns, while 2% (n = 3) had no concerns.

Concerns about how safe was the dispensing of off-label medicine use in children was again raised in a question that examined if participants felt that the use of off-label medicines in children may increase the likelihood of adverse drug reactions (ADRs). It was found that the majority of participants (88%, n = 132) were concerned that the prescription of off-label medicines to children may increase the chance of ADRs occurring.

A majority (94%, n = 141) of participants said that they had rechecked the doses of the medicines being prescribed to the Pediatric patients when a calculation was required in determining the required dosage. Interestingly, 48% (n = 72) of the participants had encountered an error in the dosage of a pediatric prescription during their professional career. When asked about their personal roles in the dispensing of pediatric off-label medicines, the majority of the participants (78%, n = 117) agreed or strongly agreed that the pharmacist had a duty to inform the prescriber that they were prescribing medicines in an off-label manner, while 60% (n = 90) agreed or strongly agreed that the pharmacist also had a duty to inform the parents and guardians of the children to whom the medicines were being prescribed, that the medicines were off label. However, only 24% (n = 36) of the participants reported actually informing the children′s parents and guardians that such medicines were off-label, and no one requested written or verbal consent to dispense medicines in an off-label manner to their children.

Unfortunately, respondents' perceptions of off-label dispensing were not significantly affected by an of demographic parameters nor practice patterns in this study. This could be explained by the lack of awareness of such dispensing in pediatric patients.

4. Discussion {#s0050}
=============

The role of pharmacists is growing in importance in terms of ensuring the safe use of medication. This in turn requires a thorough understanding of the issues that surround the dispensing of off-label medications, especially to pediatric patients. The findings of the present study are very important in term of their contribution to the development of appropriate education and training schemes for pharmacists, as well as for policy development regarding pharmaceutical care for pediatrics. In addition to the fact that a majority of the participants were not actually familiar with the concept of off-label prescribing, most of those claimed to have obtained their knowledge through their professional experience rather than via their undergraduate or postgraduate training, which was similar to that presented by studies that dealt with general practitioners, community pharmacists, pediatrician consultants, and nurses ([@b0025], [@b0035], [@b0040], [@b0050], [@b0075]). This response, together with the finding that more than half of the participants were unfamiliar with off-label dispensing of medication, highlights a serious deficiency in the undergraduate and postgraduate education and training of pharmacy students ([@b9015]).

Although the off-label dispensing of medicines to children is common in secondary and tertiary care situations ([@b0055]), with up to 90% of the involved children being affected, only 36% of the participants to this survey admitted to knowingly dispensing such medicines, which suggests the possible failure of the participants to actually recognize off-label prescriptions. It should be noted that in a survey of UK-based general practitioners, while 74% were aware of the issue of off-label prescriptions, only 40% admitted to prescribing such medicines themselves ([@b0025]). Furthermore, similar results were found in studies carried out in Northern Ireland ([@b0040]), and Scotland ([@b0035]), where participants reported different levels of awareness of off-label prescribing but a minority of participants in all the studies admitted to prescribe, dispense or administer medicines in an off-label manner ([@b0050]).

The most common forms of off-label prescription given by the participants were: the children for whom the medicine was intended were younger than that recommended age, and dispensing a dose higher than recommended. These responses were similar to those provided by studies in Scotland and Northern Ireland ([@b0035], [@b0040]), but differing from the results of the above mentioned community-based study in the UK dealing with general practitioners, where lower doses than that recommended was reported to be the most frequent form of off-label prescription, while younger age than recommended was one of the least frequent reasons ([@b0025]). By contrast, in a study of pediatricians in Jordan, the most common form of off-label prescription was for a different indication ([@b0050]). This raises questions about the real liasone between pediatricians and pharmacists in hospitls, though pediatricians have previously reported an important role for clinical pharmacists in pediatric wards ([@b0040], [@b0050]).

Despite the high levels of concern regarding safety and efficacy of off-label prescribing, only two thirds of the participants said that they would always contact the prescriber in order to confirm the prescribed dosage. The reason for pharmacists not contacting the prescriber, however, is not clear. It may reflect a need to improve communications, especially important when one consider that hospital-based pharmacists and the prescribing pediatricians in fact work in the same location ([@b0030]). The majority of the participants also believed that they had a role in informing parents and guardians when their child\'s medicine was off-label, which is consistent with the current transform the pharmacy profession is undergoing ([@b0045]). However, the provision of such information may disturb the parent or guardian, potentially undermining confidence in both the pediatrician and the pharmacist having negative effects of drug adherence among pediatric patients ([@b0020]).

Regarding their own practices and professional experience, less than a quarter of the participants reported that they informed the parents when they dispense off-label medicines, which was similar to findings in previous studies (Mukattash, et al. 2011,). This emphasizes the need to improve communications between parents and healthcare professionals in situations when off-label prescriptions are being issued ([@b0065]). For example, a public survey study dealing with off-label prescriptions to children found that most of the participants believed that parents should be informed about such prescriptions ([@b0045]).

It is well understood that pediatric patients should be prescribed medicines that are safe and effective, and that are dispensed and administered by well-trained professionals who are up-to-date in terms of their professional knowledge and who are competent to work with children ([@b0070]). Pharmacists are encouraged to participate in the development and provision of high-quality, informative material for parents and children ([@b0090]), in particular in discussing unlicensed and off-label medicines, while at the same time involving parents in the prescription of medication to their children, allowing them some measure of choice when possible ([@b9000]). Ensuring the provision of the most reliable and appropriate pediatric medication requires sound communications between the prescriber pediatrician and the pharmacist. However, without agreed-upon standards and protocols, the situation may arise where either parties could see the other as questioning their competence and authority given the situation of off-label prescriptions ([@b0010]).

Research on the use of off-label medicine in children is still at its early stages, not only in Jordan, but in all the Middle East. In addition to this study, the views of Jordanian pediatricians have been sought previously regarding their experience and attitudes towards the use of off-label medicines in children.

It is recommended that more research on the attitudes and views of other healthcare professionals, pharmacy students, medical students, and the general public towards unlicensed and off-label medicine use in pediatric patients should take place. The issue of treatment efficacy and safety should also be addressed.

Furthermore, it is important to review the curricula and training programs of medical and pharmacy students to include important issues such as this in relation to treating pediatric patients.

4.1. Study limitations {#s0055}
----------------------

Self-report questionnaires naturally are limited with regards to accurately assess prescription, dispensing and medicine administration practices. While the participants may give "socially desirable" answers to the questions, it is hoped that the anonymity of the questionnaire will encourage honesty in their answers. This is an exploratory study that depends of respondents' memory in reporting practice-related issues, further studies should explore the nature and prevalence of off-label medicine use in pediatric patients retrospectively through reviewing prescriptions of prospectively through following up inpatients and outpatient pediatric patients.

5. Conclusion {#s0060}
=============

This survey sought the perceptions and attitudes of hospital-based pharmacists towards the dispensing of off-label medicines to children. Although, as in other studies, it was reported what people 'say they do' rather than 'what they actually do', the following general conclusions can be drawn: The majority of participants were not familiar with the concept of off-label medicines. For those that did know about this issue, while reporting to have gained their knowledge from their professional experience, only a minority of participants reported that they knowingly dispensed off-label medicines for pediatric patients. Participants indicated that manufacturing more appropriate formulations for pediatric patients would reduce such practices in this population. Having concerns regarding the efficacy and safety of off-label medicines used for pediatric patients, participants felt that the use of off-label medicines would increase the likelihood of adverse drug reactions (ADRs). Finally, the participants felt that the practice of prescribing and dispensing should receive parental consent.
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[^1]: N, The total number of respondents.
